Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL
Abstract
The V3 region of HIV-1 gp120 is important for virus-coreceptor interaction and highly immunogenic. Although most anti-V3 antibodies neutralize only the sensitive tier 1 viruses, anti-V3 antibodies effective against the more resistant viruses exist, and a better understanding of these antibodies and their epitopes would be beneficial for the development of novel vaccine immunogens against HIV. The HIV-1 isolate JRFL with its cryptic V3 is resistant to most V3-specific monoclonal antibodies (MAbs). However, the V3 MAb 2424 achieves 100% neutralization against JRFL. 2424 is encoded by IGHV3-53 and IGLV2-28 genes, a pairing rarely used by the other V3 MAbs. 2424 also has distinct binding and neutralization profiles. Studies of 2424-mediated neutralization of JRFL produced with a mannosidase inhibitor further revealed that its neutralizing activity is unaffected by the glycan composition of the virus envelope. To understand the distinct activity of 2424, we determined the crystal structure of 2424 Fab in complex with a JRFL V3 peptide and showed that the 2424 epitope is located at the tip of the V3 crown (307IHIGPGRAFYT319), dominated by interactions with HisP308, ProP313, and ArgP315. The binding mode of 2424 is similar to that of the well-characterized MAb 447-52D, although 2424 is more side chainmore »
- Authors:
-
- Veterans Affairs New York Harbor Healthcare System, New York, NY (United States); NYU School of Medicine, New York, NY (United States)
- NYU School of Medicine, NY (United States)
- Veterans Affairs New York Harbor Healthcare System, New York, NY (United States); NYU School of Medicine, New York, NY (United States); Univ. de Strasbourg (France)
- Harvard Medical School, Boston, MA (United States)
- Publication Date:
- Research Org.:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Org.:
- USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH); National Cancer Inst.; National Inst. of General Medical Sciences
- OSTI Identifier:
- 1213730
- Grant/Contract Number:
- AC02-06CH11357; AI102740; AI100151; AI082274; Y1-CO-1020; Y1-GM-1104
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Journal of Virology
- Additional Journal Information:
- Journal Volume: 89; Journal Issue: 17; Journal ID: ISSN 0022-538X
- Publisher:
- American Society for Microbiology
- Country of Publication:
- United States
- Language:
- ENGLISH
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Kumar, Rajnish, Pan, Ruimin, Upadhyay, Chitra, Mayr, Luzia, Cohen, Sandra, Wang, Xiao-Hong, Balasubramanian, Preetha, Nádas, Arthur, Seaman, Michael S., Zolla-Pazner, Susan, Gorny, Miroslaw K., Kong, Xiang-Peng, and Hioe, Catarina E. Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL. United States: N. p., 2015.
Web. doi:10.1128/JVI.01280-15.
Kumar, Rajnish, Pan, Ruimin, Upadhyay, Chitra, Mayr, Luzia, Cohen, Sandra, Wang, Xiao-Hong, Balasubramanian, Preetha, Nádas, Arthur, Seaman, Michael S., Zolla-Pazner, Susan, Gorny, Miroslaw K., Kong, Xiang-Peng, & Hioe, Catarina E. Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL. United States. https://doi.org/10.1128/JVI.01280-15
Kumar, Rajnish, Pan, Ruimin, Upadhyay, Chitra, Mayr, Luzia, Cohen, Sandra, Wang, Xiao-Hong, Balasubramanian, Preetha, Nádas, Arthur, Seaman, Michael S., Zolla-Pazner, Susan, Gorny, Miroslaw K., Kong, Xiang-Peng, and Hioe, Catarina E. Wed .
"Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL". United States. https://doi.org/10.1128/JVI.01280-15. https://www.osti.gov/servlets/purl/1213730.
@article{osti_1213730,
title = {Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL},
author = {Kumar, Rajnish and Pan, Ruimin and Upadhyay, Chitra and Mayr, Luzia and Cohen, Sandra and Wang, Xiao-Hong and Balasubramanian, Preetha and Nádas, Arthur and Seaman, Michael S. and Zolla-Pazner, Susan and Gorny, Miroslaw K. and Kong, Xiang-Peng and Hioe, Catarina E.},
abstractNote = {The V3 region of HIV-1 gp120 is important for virus-coreceptor interaction and highly immunogenic. Although most anti-V3 antibodies neutralize only the sensitive tier 1 viruses, anti-V3 antibodies effective against the more resistant viruses exist, and a better understanding of these antibodies and their epitopes would be beneficial for the development of novel vaccine immunogens against HIV. The HIV-1 isolate JRFL with its cryptic V3 is resistant to most V3-specific monoclonal antibodies (MAbs). However, the V3 MAb 2424 achieves 100% neutralization against JRFL. 2424 is encoded by IGHV3-53 and IGLV2-28 genes, a pairing rarely used by the other V3 MAbs. 2424 also has distinct binding and neutralization profiles. Studies of 2424-mediated neutralization of JRFL produced with a mannosidase inhibitor further revealed that its neutralizing activity is unaffected by the glycan composition of the virus envelope. To understand the distinct activity of 2424, we determined the crystal structure of 2424 Fab in complex with a JRFL V3 peptide and showed that the 2424 epitope is located at the tip of the V3 crown (307IHIGPGRAFYT319), dominated by interactions with HisP308, ProP313, and ArgP315. The binding mode of 2424 is similar to that of the well-characterized MAb 447-52D, although 2424 is more side chain dependent. The 2424 epitope is focused on the very apex of V3, away from nearby glycans, facilitating antibody access. Lastly, this feature distinguishes the 2424 epitope from the other V3 crown epitopes and indicates that the tip of V3 is a potential site to target and incorporate into HIV vaccine immunogens.},
doi = {10.1128/JVI.01280-15},
journal = {Journal of Virology},
number = 17,
volume = 89,
place = {United States},
year = {Wed Jun 24 00:00:00 EDT 2015},
month = {Wed Jun 24 00:00:00 EDT 2015}
}
Free Publicly Available Full Text
Publisher's Version of Record
Other availability
Search WorldCat to find libraries that may hold this journal
Cited by: 9 works
Citation information provided by
Web of Science
Web of Science
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of 1->2 Mannose Residues on the Outer Face of gp120
journal, July 2002
- Scanlan, C. N.; Pantophlet, R.; Wormald, M. R.
- Journal of Virology, Vol. 76, Issue 14
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
journal, September 2012
- Huang, Jinghe; Ofek, Gilad; Laub, Leo
- Nature, Vol. 491, Issue 7424
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
journal, September 2014
- Huang, Jinghe; Kang, Byong H.; Pancera, Marie
- Nature, Vol. 515, Issue 7525
Structure of Antibody F425-B4e8 in Complex with a V3 Peptide Reveals a New Binding Mode for HIV-1 Neutralization
journal, January 2008
- Bell, Christian H.; Pantophlet, Ralph; Schiefner, André
- Journal of Molecular Biology, Vol. 375, Issue 4
Broad neutralization coverage of HIV by multiple highly potent antibodies
journal, September 2011
- Walker, Laura M.; Huber, Michael; Doores, Katie J.
- Nature, Vol. 477, Issue 7365
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
journal, October 2011
- Diskin, R.; Scheid, J. F.; Marcovecchio, P. M.
- Science, Vol. 334, Issue 6060
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
journal, September 2013
- Gottardo, Raphael; Bailer, Robert T.; Korber, Bette T.
- PLoS ONE, Vol. 8, Issue 9
Distinct Mechanisms Regulate Exposure of Neutralizing Epitopes in the V2 and V3 Loops of HIV-1 Envelope
journal, August 2014
- Upadhyay, C.; Mayr, L. M.; Zhang, J.
- Journal of Virology, Vol. 88, Issue 21
A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site
journal, August 2015
- Li, Liuzhe; Wang, Xiao-Hong; Williams, Constance
- Molecular Immunology, Vol. 66, Issue 2
Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein
journal, July 2012
- Klein, Florian; Gaebler, Christian; Mouquet, Hugo
- The Journal of Experimental Medicine, Vol. 209, Issue 8
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope
journal, September 2009
- Zolla-Pazner, Susan; Cohen, Sandra; Pinter, Abraham
- Virology, Vol. 392, Issue 1
Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody
journal, February 1992
- Emini, E. A.; Schleif, W. A.; Nunberg, J. H.
- Nature, Vol. 355, Issue 6362
Quantitative assessment of masking of neutralization epitopes in HIV-1
journal, September 2011
- Agarwal, Alpna; Hioe, Catarina E.; Swetnam, James
- Vaccine, Vol. 29, Issue 39
Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure
journal, December 2011
- Gorny, Miroslaw K.; Sampson, Jared; Li, Huiguang
- PLoS ONE, Vol. 6, Issue 12
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
journal, May 1996
- Feng, Y.; Broder, C. C.; Kennedy, P. E.
- Science, Vol. 272, Issue 5263
A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization
journal, February 2013
- Wang, Wenbo; Nie, Jianhui; Prochnow, Courtney
- Retrovirology, Vol. 10, Issue 1
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
journal, June 1998
- Kwong, Peter D.; Wyatt, Richard; Robinson, James
- Nature, Vol. 393, Issue 6686
Antibodies to the HIV-1 V3 Loop in Serum from Infected Persons Contribute a Major Proportion of Immune Effector Functions Including Complement Activation, Antibody Binding, and Neutralization
journal, November 1994
- Spear, Gregory T.; Takefman, Daniel M.; Sharpe, Sandra
- Virology, Vol. 204, Issue 2
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
journal, March 2009
- Scheid, Johannes F.; Mouquet, Hugo; Feldhahn, Niklas
- Nature, Vol. 458, Issue 7238
Factors Determining the Breadth and Potency of Neutralization by V3-Specific Human Monoclonal Antibodies Derived from Subjects Infected with Clade A or Clade B Strains of Human Immunodeficiency Virus Type 1
journal, July 2006
- Krachmarov, C. P.; Honnen, W. J.; Kayman, S. C.
- Journal of Virology, Vol. 80, Issue 14
Identification of a major co-receptor for primary isolates of HIV-1
journal, June 1996
- Deng, HongKui; Liu, Rong; Ellmeier, Wilfried
- Nature, Vol. 381, Issue 6584
Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein.
journal, April 1991
- Gorny, M. K.; Xu, J. Y.; Gianakakos, V.
- Proceedings of the National Academy of Sciences, Vol. 88, Issue 8
Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays
journal, December 2004
- Montefiori, David C.
- Current Protocols in Immunology, Vol. 64, Issue 1
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits
journal, April 2009
- Burke, Brian; Gómez-Román, Victor Raúl; Lian, Ying
- Virology, Vol. 387, Issue 1
Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
journal, November 2014
- Zolla-Pazner, Susan; Edlefsen, Paul T.; Rolland, Morgane
- EBioMedicine, Vol. 1, Issue 1
Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain Exchanged
journal, August 2010
- Doores, Katie J.; Fulton, Zara; Huber, Michael
- Journal of Virology, Vol. 84, Issue 20
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
journal, June 1996
- Dragic, Tatjana; Litwin, Virginia; Allaway, Graham P.
- Nature, Vol. 381, Issue 6584
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
journal, July 2010
- Wu, X.; Yang, Z. -Y.; Li, Y.
- Science, Vol. 329, Issue 5993
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
journal, November 2009
- Seaman, M. S.; Janes, H.; Hawkins, N.
- Journal of Virology, Vol. 84, Issue 3
Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines
journal, November 2013
- Kumar, Rajnish; Tuen, Michael; Liu, Jianping
- Vaccine, Vol. 31, Issue 46
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
journal, July 2005
- Li, M.; Gao, F.; Mascola, J. R.
- Journal of Virology, Vol. 79, Issue 16
XDS
journal, January 2010
- Kabsch, Wolfgang
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2
Removal of a Single N-Linked Glycan in Human Immunodeficiency Virus Type 1 gp120 Results in an Enhanced Ability To Induce Neutralizing Antibody Responses
journal, October 2007
- Li, Yun; Cleveland, Bradley; Klots, Igor
- Journal of Virology, Vol. 82, Issue 2
Clonal analysis of human anti-V3 monoclonal antibodies selected by a V3 tetramer
journal, March 2013
- Li, Liuzhe; Wang, Xiao-Hong; Banerjee, Sagarika
- Human Antibodies, Vol. 21, Issue 3-4
Anti-V3 Monoclonal Antibodies Display Broad Neutralizing Activities against Multiple HIV-1 Subtypes
journal, April 2010
- Hioe, Catarina E.; Wrin, Terri; Seaman, Michael S.
- PLoS ONE, Vol. 5, Issue 4
Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16
journal, August 2010
- Doores, Katie J.; Burton, Dennis R.
- Journal of Virology, Vol. 84, Issue 20
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant
journal, August 1990
- LaRosa, G.; Davide, J.; Weinhold, K.
- Science, Vol. 249, Issue 4971
High Prevalence of Antibodies to the gp120 V3 Region Principal Neutralizing Determinant of HIV-1 MN in Sera from Africa and the Americas
journal, October 1991
- Carrow, Emily W.; Vujcic, Luba K.; Glass, Wendy L.
- AIDS Research and Human Retroviruses, Vol. 7, Issue 10
Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades
journal, September 2002
- Gorny, Miroslaw K.; Williams, Constance; Volsky, Barbara
- Journal of Virology, Vol. 76, Issue 18
A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding
journal, June 1998
- Rizzuto, C. D.
- Science, Vol. 280, Issue 5371
Coot model-building tools for molecular graphics
journal, November 2004
- Emsley, Paul; Cowtan, Kevin
- Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
journal, September 2009
- Walker, L. M.; Phogat, S. K.; Chan-Hui, P. -Y.
- Science, Vol. 326, Issue 5950
Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D
journal, February 2004
- Stanfield, Robyn L.; Gorny, Miroslaw K.; Williams, Constance
- Structure, Vol. 12, Issue 2
A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1
journal, August 2013
- Gach, Johannes S.; Quendler, Heribert; Tong, Tommy
- PLoS ONE, Vol. 8, Issue 8
ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation
journal, May 1994
- Abagyan, Ruben; Totrov, Maxim; Kuznetsov, Dmitry
- Journal of Computational Chemistry, Vol. 15, Issue 5
Cross-Clade Neutralizing Activity of Human Anti-V3 Monoclonal Antibodies Derived from the Cells of Individuals Infected with Non-B Clades of Human Immunodeficiency Virus Type 1
journal, June 2006
- Gorny, M. K.; Williams, C.; Volsky, B.
- Journal of Virology, Vol. 80, Issue 14
PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010
- Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
journal, August 1991
- Sattentau, Q. J.; Moore, J. P.
- The Journal of Experimental Medicine, Vol. 174, Issue 2
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
journal, August 1993
- Montefiori, D. C.; Graham, B. S.; Zhou, J.
- Journal of Clinical Investigation, Vol. 92, Issue 2
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
journal, October 2011
- Pejchal, R.; Doores, K. J.; Walker, L. M.
- Science, Vol. 334, Issue 6059
The V1, V2, and V3 Regions of the Human Immunodeficiency Virus Type 1 Envelope Differentially Affect the Viral Phenotype in an Isolate-Dependent Manner
journal, July 2005
- Saunders, Cheryl J.; McCaffrey, Ruth A.; Zharkikh, Irina
- Journal of Virology, Vol. 79, Issue 14
Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy
journal, June 2014
- Murin, C. D.; Julien, J. -P.; Sok, D.
- Journal of Virology, Vol. 88, Issue 17
The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
journal, November 2013
- Sok, Devin; Laserson, Uri; Laserson, Jonathan
- PLoS Pathogens, Vol. 9, Issue 11
Autoreactivity in Human IgG+ Memory B Cells
journal, February 2007
- Tiller, Thomas; Tsuiji, Makoto; Yurasov, Sergey
- Immunity, Vol. 26, Issue 2
Progress in HIV-1 vaccine development
journal, July 2014
- Haynes, Barton F.; Moody, M. Anthony; Alam, Munir
- Journal of Allergy and Clinical Immunology, Vol. 134, Issue 1
Conserved structural elements in the V3 crown of HIV-1 gp120
journal, July 2010
- Jiang, Xunqing; Burke, Valicia; Totrov, Maxim
- Nature Structural & Molecular Biology, Vol. 17, Issue 8
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein
journal, October 1986
- Lifson, Jeffrey D.; Feinberg, Mark B.; Reyes, Gregory R.
- Nature, Vol. 323, Issue 6090
Role of Complex Carbohydrates in Human Immunodeficiency Virus Type 1 Infection and Resistance to Antibody Neutralization
journal, March 2010
- Binley, James M.; Ban, Yih-En Andrew; Crooks, Emma T.
- Journal of Virology, Vol. 84, Issue 11
The V3 Loop Is Accessible on the Surface of Most Human Immunodeficiency Virus Type 1 Primary Isolates and Serves as a Neutralization Epitope
journal, March 2004
- Gorny, Miroslaw K.; Revesz, Kathy; Williams, Constance
- Journal of Virology, Vol. 78, Issue 5
HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages
journal, May 2012
- Moody, M. A.; Yates, N. L.; Amos, J. D.
- Journal of Virology, Vol. 86, Issue 14
Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1
journal, February 2009
- Gorny, Miroslaw K.; Wang, Xiao-Hong; Williams, Constance
- Molecular Immunology, Vol. 46, Issue 5
Diversity Considerations in HIV-1 Vaccine Selection
journal, June 2002
- Gaschen, Brian; Taylor, Jesse; Yusim, Karina
- Science, Vol. 296, Issue 5577, p. 2354-2360
Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based Immunogens
journal, November 2009
- Burke, Valicia; Williams, Constance; Sukumaran, Madhav
- Structure, Vol. 17, Issue 11
Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies
journal, November 2010
- Vaine, Michael; Wang, Shixia; Liu, Qin
- PLoS ONE, Vol. 5, Issue 11
Complete Nucleotide Sequences of Functional Clones of the AIDS Virus
journal, January 1987
- Ratner, Lee; Fisher, Amanda; Jagodzinski, Linda L.
- AIDS Research and Human Retroviruses, Vol. 3, Issue 1
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions.
journal, January 1987
- Modrow, S.; Hahn, B. H.; Shaw, G. M.
- Journal of Virology, Vol. 61, Issue 2
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
journal, January 1996
- Trkola, A.; Purtscher, M.; Muster, T.
- Journal of virology, Vol. 70, Issue 2
Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein
journal, December 1997
- Cao, J.; Sullivan, N.; Desjardin, E.
- Journal of Virology, Vol. 71, Issue 12
Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
journal, March 1999
- Gigler, Andreas; Dorsch, Simone; Hemauer, Andrea
- Journal of Virology, Vol. 73, Issue 3
Works referencing / citing this record:
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
journal, July 2019
- Han, Qifeng; Jones, Julia A.; Nicely, Nathan I.
- Nature Communications, Vol. 10, Issue 1